{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:52:16Z","timestamp":1789501936850,"version":"build-2803163510"},"reference-count":722,"publisher":"Informa UK Limited","issue":"9","funder":[{"name":"Overseas Research Fellow Award"},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMW","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"de Hetrsenstichting"},{"name":"Dutch Ministry of Health"},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Institute for Quality and Efficiency in Health Care"},{"name":"Janssen-Cilag, Lundbeck, MindMed, Otsuka, Recordati, Roche, ROVI, and Takeda"},{"name":"Beckley Psytech and Boehringer Ingelheim"},{"DOI":"10.13039\/100000046","name":"Abbott","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"Abbvie","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006546","name":"Angelini","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006546","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Astra Zeneca"},{"name":"Clinical Data"},{"name":"Boheringer"},{"name":"Bristol Myers Squibb"},{"name":"Eli Lilly"},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovapharma"},{"DOI":"10.13039\/501100014383","name":"Italfarmaco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014383","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Janssen"},{"DOI":"10.13039\/501100013327","name":"Lundbeck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Naurex"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Polifarma"},{"DOI":"10.13039\/100019944","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019944","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Taliaz"},{"name":"Daiichi Sankyo, Eisai, Mochida, Otsuka, and Sumitomo Pharma"},{"name":"Eisai, Lundbeck, Meiji Seika Pharma, Otsuka, and Sumitomo Pharma"},{"name":"Lundbeck, Sumitomo Pharma, Takeda Pharmaceutical Company, and Boehringer Ingelheim Japan"},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004948","name":"Astellas Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Signant Health"},{"name":"Asahi Quality & Innovations, Ltd"},{"name":"Sumitomo Pharma, Meiji- Seika Pharma, Otsuka Pharmaceutical, and MSD"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["The World Journal of Biological Psychiatry"],"published-print":{"date-parts":[[2024,10,20]]},"DOI":"10.1080\/15622975.2024.2366235","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T18:42:55Z","timestamp":1719254575000},"page":"451-536","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":35,"title":["Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: Focus on antipsychotics"],"prefix":"10.1080","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6033-0189","authenticated-orcid":false,"given":"Xenia Marlene","family":"Hart","sequence":"first","affiliation":[{"name":"Department of Molecular Neuroimaging, Medical Faculty Mannheim, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany"},{"name":"Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Gr\u00fcnder","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan"},{"name":"German Center for Mental Health (DZPG), Partner Site Mannheim, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Ansermot","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neuroscience, Lausanne University Hospital, Prilly, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4841-7510","authenticated-orcid":false,"given":"Andreas","family":"Conca","sequence":"additional","affiliation":[{"name":"Dipartimento di Psichiatria, Comprensorio Sanitario di Bolzano, Bolzano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Corruble","sequence":"additional","affiliation":[{"name":"Service Hospitalo-Universitaire de Psychiatrie, H\u00f4pital de Bic\u00eatre, Universit\u00e9 Paris-Saclay, AP-HP, Le Kremlin-Bic\u00eatre, France"},{"name":"Equipe MOODS, Inserm U1018, CESP (Centre de Recherche en Epid\u00e9miologie et Sante des Populations), Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severine","family":"Crettol","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neuroscience, Lausanne University Hospital, Prilly, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0257-9621","authenticated-orcid":false,"given":"Paul","family":"Cumming","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Bern University Hospital, Bern, Switzerland"},{"name":"School of Psychology and Counseling, Queensland University of Technology, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4441-3873","authenticated-orcid":false,"given":"Ariel","family":"Frajerman","sequence":"additional","affiliation":[{"name":"Service Hospitalo-Universitaire de Psychiatrie, H\u00f4pital de Bic\u00eatre, Universit\u00e9 Paris-Saclay, AP-HP, Le Kremlin-Bic\u00eatre, France"},{"name":"Equipe MOODS, Inserm U1018, CESP (Centre de Recherche en Epid\u00e9miologie et Sante des Populations), Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun","family":"Hefner","sequence":"additional","affiliation":[{"name":"Forensic Psychiatry, Vitos Clinic for Forensic Psychiatry, Eltville, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2928-1972","authenticated-orcid":false,"given":"Oliver","family":"Howes","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, IoPPN, King\u2019s College London, London, UK"},{"name":"Faculty of Medicine, Institute of Clinical Sciences (ICS), Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5296-4245","authenticated-orcid":false,"given":"Marin\u00a0M.","family":"Jukic","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia"},{"name":"Pharmacogenetics Section, Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euitae","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seoyoung","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8472-8324","authenticated-orcid":false,"given":"Ignazio","family":"Maniscalco","sequence":"additional","affiliation":[{"name":"Dipartimento di Psichiatria, Comprensorio Sanitario di Bolzano, Bolzano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7536-9708","authenticated-orcid":false,"given":"Sho","family":"Moriguchi","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4978-4400","authenticated-orcid":false,"given":"Daniel J.","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital of W\u00fcrzburg, W\u00fcrzburg, Germany"},{"name":"Pharmacogenetics Research Clinic, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada"},{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2601-2195","authenticated-orcid":false,"given":"Shinichiro","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Osugo","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, IoPPN, King\u2019s College London, London, UK"},{"name":"Faculty of Medicine, Institute of Clinical Sciences (ICS), Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Paulzen","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Psychotherapy and Psychosomatics, RWTH Aachen University, Aachen, Germany"},{"name":"JARA \u2013 Translational Brain Medicine, Alexianer Center for Mental Health, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6072-0358","authenticated-orcid":false,"given":"Henricus Gerardus","family":"Ruhe","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Radboudumc, Nijmegen, Netherlands"},{"name":"Donders Institute for Brain, Cognition and Behavior, Radboud University, Nijmegen, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Scherf-Clavel","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital of W\u00fcrzburg, W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3851-4117","authenticated-orcid":false,"given":"Georgios","family":"Schoretsanitis","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4363-3759","authenticated-orcid":false,"given":"Alessandro","family":"Serretti","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, Kore University of Enna, Enna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2509-7449","authenticated-orcid":false,"given":"Edoardo","family":"Spina","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olav","family":"Spigset","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, St. Olav University Hospital, Trondheim, Norway"},{"name":"Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Steimer","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry and Pathobiochemistry, Technical University Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinan H.","family":"S\u00fczen","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutic Toxicology, Faculty of Pharmacy, Ankara University, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Uchida","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Unterecker","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital of W\u00fcrzburg, W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8964-2047","authenticated-orcid":false,"given":"Frederik","family":"Vandenberghe","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neuroscience, Lausanne University Hospital, Prilly, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8534-224X","authenticated-orcid":false,"given":"Celine","family":"Verstuyft","sequence":"additional","affiliation":[{"name":"Equipe MOODS, Inserm U1018, CESP (Centre de Recherche en Epid\u00e9miologie et Sante des Populations), Le Kremlin-Bic\u00eatre, France"},{"name":"Department of Molecular Genetics, Pharmacogenetics and Hormonology, Bic\u00eatre University Hospital Paris-Saclay, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Zernig","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Medical University Innsbruck, Hall in Tirol, Austria"},{"name":"Private Practice for Psychotherapy and Court-Certified Witness, Hall in Tirol, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2820-8738","authenticated-orcid":false,"given":"Christoph","family":"Hiemke","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy and Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center of Mainz, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5439-0230","authenticated-orcid":false,"given":"Chin B.","family":"Eap","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neuroscience, Lausanne University Hospital, Prilly, Switzerland"},{"name":"School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland"},{"name":"Center for Research and Innovation in Clinical Pharmaceutical Sciences, University of Lausanne, Lausanne, Switzerland"},{"name":"Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, University of Lausanne, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,9]]},"reference":[{"key":"e_1_3_3_2_1","unstructured":"Acacia Pharma Inc. 2020. Amisulpride: highlights of prescribing information. Retrieved from https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/209510s000lbl.pdf"},{"issue":"6","key":"e_1_3_3_3_1","first-page":"1156","article-title":"Antipsychotic efficacy in relation to plasma levels of clozapine","volume":"26","author":"Ackenheil M","year":"1976","unstructured":"Ackenheil M, Br\u00e4u H, Burkhart A, Franke A, Pacha W. 1976. Antipsychotic efficacy in relation to plasma levels of clozapine. Arzneimittelforschung. 26(6):1156\u20131158.","journal-title":"Arzneimittelforschung"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003082.pub3"},{"key":"e_1_3_3_5_1","unstructured":"Administration USFD clinical pharmacology and biopharmaceutics review of lurasidone. 2010. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2010\/200603Orig1s000ClinPharmR.pdf"},{"key":"e_1_3_3_6_1","unstructured":"Administration USFD Navane. 2009. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/016584s059lbl.pdf"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e3282f01aa3"},{"key":"e_1_3_3_8_1","volume-title":"Ze clinical pharmacology and biopharmaceutics review of brexpiprazole","author":"al","year":"2014","unstructured":"al. 2014. Ze clinical pharmacology and biopharmaceutics review of brexpiprazole. Center for Drug Evaluation and Research, Food and Drug Administration (Application number 205422Orig1s000 and 205422Orig2s000). Center for drug evaluation and reserach, https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/016584s059lbl.pdf"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-109695"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.17.1.61"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1984.tb06859.x"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2018-0163"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200363050-00004"},{"key":"e_1_3_3_14_1","unstructured":"AMA. 1994. AMA drug evaluations annual. United States Pharmacopeia p. 2400 December 1993 ISBN 0899706029."},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41397-021-00231-x"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.22f14722"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050301"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjopharm.2008.10.003"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2009.07.009"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2000.00155.x"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-010-1783-1"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-007-1029-z"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600820503"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-020-05715-5"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-019-0511-9"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2018.10.036"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890424841"},{"key":"e_1_3_3_28_1","unstructured":"Australian Government Department of Health and Ageing Therapeutic Goods Administration. 2022."},{"key":"e_1_3_3_29_1","unstructured":"Australian public assessment report for asenapine [accessed 2022 Nov 9]. https:\/\/www.tga.gov.au\/sites\/default\/files\/auspar-saphris.pdf."},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2000.00150.x"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1004590"},{"issue":"12","key":"e_1_3_3_32_1","first-page":"646","article-title":"Bioequivalence and absolute bioavailability of oblong and coated levomepromazine tablets in CYP2D6 phenotyped subjects","volume":"33","author":"Bagli M","year":"1995","unstructured":"Bagli M, H\u00f6flich G, Rao ML, Langer M, Baumann P, Kolbinger M, Barlage U, Kasper S, M\u00f6ller HJ. 1995. Bioequivalence and absolute bioavailability of oblong and coated levomepromazine tablets in CYP2D6 phenotyped subjects. Int J Clin Pharmacol Ther. 33(12):646\u2013652.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002083.pub2"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-019-05311-2"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198713020-00001"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03189886"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-198512000-00008"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-3659(00)00337-0"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.30303"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130100813"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharep.2015.04.005"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-012-2699-8"},{"key":"e_1_3_3_43_1","volume-title":"Psychotropic drug directory 2020\/21: the professionals\u2019 pocket handbook and aide memoire","author":"Bazire S.","year":"2020","unstructured":"Bazire S. 2020. Psychotropic drug directory 2020\/21: the professionals\u2019 pocket handbook and aide memoire. Healthcomm UK, Aberdeen: Lloyd-Reinhold Publications."},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000084028.22282.f2"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.12960"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245614"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200404000-00010"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e3283331637"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-023-01347-3"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200161010-00011"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000435"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31828b28d5"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2010.46.8.1509989"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00341611"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00367389"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1990.tb01229.x"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00545974"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2014.83"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2017015"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.8.1413"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198917050-00005"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1019491"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00181950"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.49.2.176"},{"key":"e_1_3_3_65_1","volume-title":"Goodman and Gilman\u2019s the pharmacological basis of therapeutics","author":"Brunton LL","year":"2017","unstructured":"Brunton LL, Hilal-Dandan R, Knollmann BC. Goodman and Gilman\u2019s the pharmacological basis of therapeutics. 13th ed. New York: Mcgraw-Hill; 2017.","edition":"13"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2308"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.4236\/ojpsych.2013.31008"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S35137"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2021.20091339"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199937030-00001"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-894X(96)00567-7"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2004.10.020"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.490"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200304000-00003"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200502000-00019"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881107083810"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001461"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.151.1.123"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001943.pub2"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130051036"},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1638403"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-009-1538-z"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-013-0167-9"},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01046700"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31818ac8ba"},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0924-977x(98)00005-4"},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1999.tb00832.x"},{"key":"e_1_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016434312388"},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199302000-00004"},{"issue":"5","key":"e_1_3_3_90_1","first-page":"855","article-title":"Additional studies on side effects of melperone in long-term therapy for 1\u201320 years in psychiatric patients","volume":"36","author":"Christensen I","year":"1986","unstructured":"Christensen I, Geismar L, Kirkegaard A, Kirkegaard G. 1986. Additional studies on side effects of melperone in long-term therapy for 1\u201320 years in psychiatric patients. Arzneimittelforschung. 36(5):855\u2013860.","journal-title":"Arzneimittelforschung"},{"key":"e_1_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116654698"},{"key":"e_1_3_3_92_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181a289cb"},{"key":"e_1_3_3_93_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2013.759211"},{"key":"e_1_3_3_94_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S159704"},{"key":"e_1_3_3_95_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198712000-00002"},{"key":"e_1_3_3_96_1","unstructured":"Clorazil full prescribing information: US Food and Drug Administration; 1989. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/019758s084lbl.pdf"},{"key":"e_1_3_3_97_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2000-8355"},{"key":"e_1_3_3_98_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-198704000-00008"},{"key":"e_1_3_3_99_1","doi-asserted-by":"publisher","DOI":"10.1159\/000468174"},{"key":"e_1_3_3_100_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1975183325"},{"key":"e_1_3_3_101_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-015-0092-x"},{"key":"e_1_3_3_102_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2019.4379"},{"key":"e_1_3_3_103_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S210340"},{"key":"e_1_3_3_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pscychresns.2011.02.004"},{"key":"e_1_3_3_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(90)90298-v"},{"key":"e_1_3_3_106_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-199606030-00006"},{"key":"e_1_3_3_107_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.3854"},{"key":"e_1_3_3_108_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006163"},{"key":"e_1_3_3_109_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1970.01740280001001"},{"key":"e_1_3_3_110_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1979.tb00941.x"},{"key":"e_1_3_3_111_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000119"},{"key":"e_1_3_3_112_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1977.tb00175.x"},{"key":"e_1_3_3_113_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1994.tb04242.x"},{"key":"e_1_3_3_114_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241070-00001"},{"key":"e_1_3_3_115_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00607681"},{"key":"e_1_3_3_116_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1976194435"},{"key":"e_1_3_3_117_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-198204000-00005"},{"key":"e_1_3_3_118_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198611010-00003"},{"key":"e_1_3_3_119_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1989.109"},{"key":"e_1_3_3_120_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-018-0517-5"},{"key":"e_1_3_3_121_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.11.279"},{"key":"e_1_3_3_122_1","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-020-00157-4"},{"key":"e_1_3_3_123_1","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-020-00102-5"},{"issue":"2","key":"e_1_3_3_124_1","first-page":"127","article-title":"The pharmacokinetics of promazine and its metabolites after acute and chronic administration to rats\u2013a comparison with the pharmacokinetics of imipramine","volume":"47","author":"Daniel W","year":"1995","unstructured":"Daniel W, Syrek M, Janczar L, Boksa J. 1995. The pharmacokinetics of promazine and its metabolites after acute and chronic administration to rats\u2013a comparison with the pharmacokinetics of imipramine. Pol J Pharmacol. 47(2):127\u2013136.","journal-title":"Pol J Pharmacol"},{"key":"e_1_3_3_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(96)00141-5"},{"key":"e_1_3_3_126_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2010.01619.x"},{"key":"e_1_3_3_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-008055232-3.62472-9"},{"key":"e_1_3_3_128_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-015-3922-1"},{"key":"e_1_3_3_129_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-010-9247-4"},{"key":"e_1_3_3_130_1","doi-asserted-by":"publisher","DOI":"10.1055\/a-1625-6388"},{"key":"e_1_3_3_131_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000705"},{"key":"e_1_3_3_132_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000738"},{"key":"e_1_3_3_133_1","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.41.3.369"},{"key":"e_1_3_3_134_1","doi-asserted-by":"publisher","DOI":"10.1080\/15622975.2018.1548779"},{"key":"e_1_3_3_135_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e3283602e75"},{"key":"e_1_3_3_136_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2011.70"},{"key":"e_1_3_3_137_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e32834e9e1a"},{"key":"e_1_3_3_138_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-013-1587-4"},{"key":"e_1_3_3_139_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-014-9649-9"},{"key":"e_1_3_3_140_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199812000-00011"},{"key":"e_1_3_3_141_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-69535-8_8"},{"key":"e_1_3_3_142_1","unstructured":"Drug USF Drug Approval Package Ziprasidone. 2001. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2001\/20-825_geodan.cfm"},{"key":"e_1_3_3_143_1","doi-asserted-by":"publisher","DOI":"10.1002\/gps.2737"},{"key":"e_1_3_3_144_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2019.02.017"},{"key":"e_1_3_3_145_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00422403"},{"key":"e_1_3_3_146_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000116646.91923.2f"},{"key":"e_1_3_3_147_1","doi-asserted-by":"publisher","DOI":"10.1080\/15622975.2021.1878427"},{"key":"e_1_3_3_148_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2003.11.001"},{"key":"e_1_3_3_149_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1997.t01-1-00605.x"},{"key":"e_1_3_3_150_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199529060-00005"},{"key":"e_1_3_3_151_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2016.11.007"},{"key":"e_1_3_3_152_1","doi-asserted-by":"publisher","DOI":"10.1002\/syn.21566"},{"key":"e_1_3_3_153_1","doi-asserted-by":"publisher","DOI":"10.1211\/0022357043969"},{"key":"e_1_3_3_154_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.12.187"},{"key":"e_1_3_3_155_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1946"},{"key":"e_1_3_3_156_1","unstructured":"EMA Assessment report of lurasidone. 2014. https:\/\/www.ema.europa.eu\/en\/documents\/assessment-report\/latuda-epar-public-assessment-report_en.pdf"},{"issue":"10","key":"e_1_3_3_157_1","first-page":"20","article-title":"Pharmacologic and pharmacokinetic considerations in choosing an antipsychotic","volume":"60","author":"Ereshefsky L.","year":"1999","unstructured":"Ereshefsky L. 1999. Pharmacologic and pharmacokinetic considerations in choosing an antipsychotic. J Clin Psychiatry. 60(Suppl 10):20\u201330.","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"e_1_3_3_158_1","first-page":"50","article-title":"Future of depot neuroleptic therapy: pharmacokinetic and pharmacodynamic approaches","volume":"45","author":"Ereshefsky L","year":"1984","unstructured":"Ereshefsky L, Saklad SR, Jann MW, Davis CM, Richards A, Seidel DR. 1984. Future of depot neuroleptic therapy: pharmacokinetic and pharmacodynamic approaches. J Clin Psychiatry. 45(5\u2009Pt 2):50\u201359.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_3_159_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199906000-00017"},{"key":"e_1_3_3_160_1","doi-asserted-by":"publisher","DOI":"10.1007\/PL00005298"},{"key":"e_1_3_3_161_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(93)80318-x"},{"key":"e_1_3_3_162_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00210831"},{"key":"e_1_3_3_163_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199702001-00002"},{"key":"e_1_3_3_164_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1992.01820070032005"},{"key":"e_1_3_3_165_1","doi-asserted-by":"publisher","DOI":"10.1192\/S0007125000296888"},{"key":"e_1_3_3_166_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199502001-00004"},{"key":"e_1_3_3_167_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800250087012"},{"key":"e_1_3_3_168_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00442555"},{"key":"e_1_3_3_169_1","doi-asserted-by":"publisher","DOI":"10.1055\/a-1963-7631"},{"key":"e_1_3_3_170_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200312000-00006"},{"key":"e_1_3_3_171_1","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyx102"},{"key":"e_1_3_3_172_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2015.11.001"},{"key":"e_1_3_3_173_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(94)90647-5"},{"key":"e_1_3_3_174_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270005281044"},{"key":"e_1_3_3_175_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-013-3007-y"},{"issue":"2","key":"e_1_3_3_176_1","first-page":"939","article-title":"Positron emission tomographic analysis of Central 5-hydroxytryptamine2 receptor occupancy in healthy volunteers treated with the novel antipsychotic agent, ziprasidone","volume":"279","author":"Fischman AJ","year":"1996","unstructured":"Fischman AJ, Bonab AA, Babich JW, Alpert NM, Rauch SL, Elmaleh DR, Shoup TM, Williams SA, Rubin RH. 1996. Positron emission tomographic analysis of Central 5-hydroxytryptamine2 receptor occupancy in healthy volunteers treated with the novel antipsychotic agent, ziprasidone. J Pharmacol Exp Ther. 279(2):939\u2013947.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_3_177_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002139900333"},{"key":"e_1_3_3_178_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2791"},{"key":"e_1_3_3_179_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(96)00298-3"},{"key":"e_1_3_3_180_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1819.1984.tb00360.x"},{"key":"e_1_3_3_181_1","doi-asserted-by":"publisher","DOI":"10.1016\/0278-5846(92)90107-p"},{"key":"e_1_3_3_182_1","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2016.80"},{"key":"e_1_3_3_183_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2321"},{"issue":"6","key":"e_1_3_3_184_1","first-page":"437","article-title":"Tissue metabolites of trifluorperazine, fluphenazine, prochlorperazine, and perphenazine. Kinetics in chronic treatment","volume":"3","author":"Gaertner HJ","year":"1975","unstructured":"Gaertner HJ, Liomin G, Villumsen D, Bertele R, Breyer U. 1975. Tissue metabolites of trifluorperazine, fluphenazine, prochlorperazine, and perphenazine. Kinetics in chronic treatment. Drug Metab Dispos. 3(6):437\u2013444.","journal-title":"Drug Metab Dispos"},{"key":"e_1_3_3_185_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200106000-00010"},{"key":"e_1_3_3_186_1","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-6-49"},{"key":"e_1_3_3_187_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.19.7513"},{"key":"e_1_3_3_188_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.131.6.699"},{"key":"e_1_3_3_189_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00894-005-0063-1"},{"key":"e_1_3_3_190_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050492"},{"key":"e_1_3_3_191_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(00)00133-4"},{"key":"e_1_3_3_192_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbn107"},{"key":"e_1_3_3_193_1","unstructured":"Geodon full prescribing information. 2001. [accessed 2022 Nov 24]. www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/020825s053 020919s040 s021483s013lbl.pdf."},{"key":"e_1_3_3_194_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.147.3.283"},{"key":"e_1_3_3_195_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.718"},{"key":"e_1_3_3_196_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270011404028"},{"key":"e_1_3_3_197_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-009-0783-8"},{"key":"e_1_3_3_198_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2008.116"},{"key":"e_1_3_3_199_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-019-0590-6"},{"key":"e_1_3_3_200_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-016-4382-y"},{"key":"e_1_3_3_201_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050062"},{"key":"e_1_3_3_202_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-019-00821-w"},{"key":"e_1_3_3_203_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02246213"},{"key":"e_1_3_3_204_1","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-115-29112"},{"key":"e_1_3_3_205_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-1781(02)00028-8"},{"key":"e_1_3_3_206_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2015.0891"},{"key":"e_1_3_3_207_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-016-0465-5"},{"key":"e_1_3_3_208_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-0348-7292-8_7"},{"key":"e_1_3_3_209_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1014348"},{"key":"e_1_3_3_210_1","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e3181863239"},{"key":"e_1_3_3_211_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21072345"},{"key":"e_1_3_3_212_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.10.974"},{"key":"e_1_3_3_213_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2008.07101574"},{"key":"e_1_3_3_214_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1286282"},{"key":"e_1_3_3_215_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2806"},{"key":"e_1_3_3_216_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-931485"},{"key":"e_1_3_3_217_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300931"},{"key":"e_1_3_3_218_1","doi-asserted-by":"publisher","DOI":"10.2478\/acph-2014-0036"},{"key":"e_1_3_3_219_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2023.07.006"},{"key":"e_1_3_3_220_1","volume-title":"Sertindole: summary of product characteritics","author":"H. Lundbeck A\/S","year":"2005","unstructured":"H. Lundbeck A\/S. 2005. Sertindole: summary of product characteritics. Copenhagen: H. Lundbeck A\/S."},{"key":"e_1_3_3_221_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e318295fe12"},{"key":"e_1_3_3_222_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0925-4927(98)00020-1"},{"key":"e_1_3_3_223_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(88)90519-x"},{"key":"e_1_3_3_224_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1998.tb03820.x"},{"key":"e_1_3_3_225_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2002.01686.x"},{"key":"e_1_3_3_226_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00432245"},{"key":"e_1_3_3_227_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01277026"},{"key":"e_1_3_3_228_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0378-4347(00)83902-x"},{"key":"e_1_3_3_229_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00442557"},{"key":"e_1_3_3_230_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200418020-00005"},{"key":"e_1_3_3_231_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000001131"},{"key":"e_1_3_3_232_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-022-06233-2"},{"key":"e_1_3_3_233_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.832209"},{"key":"e_1_3_3_234_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-006-0209-9"},{"key":"e_1_3_3_235_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2012.46"},{"key":"e_1_3_3_236_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1017384"},{"key":"e_1_3_3_237_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-020-02492-5"},{"key":"e_1_3_3_238_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-020-02291-y"},{"key":"e_1_3_3_239_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-015-3976-0"},{"key":"e_1_3_3_240_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.1843"},{"key":"e_1_3_3_241_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181c17df0"},{"key":"e_1_3_3_242_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000040"},{"key":"e_1_3_3_243_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(69)90154-4"},{"key":"e_1_3_3_244_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1600991"},{"key":"e_1_3_3_245_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199408000-00011"},{"key":"e_1_3_3_246_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000582"},{"key":"e_1_3_3_247_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130100814"},{"key":"e_1_3_3_248_1","doi-asserted-by":"publisher","DOI":"10.1177\/2045125312474019"},{"key":"e_1_3_3_249_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41537-021-00170-3"},{"key":"e_1_3_3_250_1","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2016.180"},{"key":"e_1_3_3_251_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2010.03814.x"},{"key":"e_1_3_3_252_1","doi-asserted-by":"publisher","DOI":"10.1177\/02698811211003477"},{"key":"e_1_3_3_253_1","doi-asserted-by":"publisher","DOI":"10.1177\/10398562211064254"},{"key":"e_1_3_3_254_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.2510110702"},{"key":"e_1_3_3_255_1","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.13466"},{"key":"e_1_3_3_256_1","doi-asserted-by":"publisher","DOI":"10.1177\/20451253221097261"},{"key":"e_1_3_3_257_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31135-3"},{"key":"e_1_3_3_258_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000426"},{"key":"e_1_3_3_259_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00606409"},{"key":"e_1_3_3_260_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0301-0082(96)00037-8"},{"key":"e_1_3_3_261_1","unstructured":"Intra-Cellular Therapies Inc. 2019. HIGHLIGHTS OF PRESCRIBING INFORMATION: CAPLYTA (lumateperone). Retrieved from https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/209500s005s006lbl.pdf."},{"key":"e_1_3_3_262_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1991.tb03973.x"},{"key":"e_1_3_3_263_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.979"},{"key":"e_1_3_3_264_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41397-022-00281-9"},{"key":"e_1_3_3_265_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046488"},{"key":"e_1_3_3_266_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-002-1059-5"},{"key":"e_1_3_3_267_1","doi-asserted-by":"publisher","DOI":"10.1159\/000468235"},{"key":"e_1_3_3_268_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198910000-00005"},{"issue":"11","key":"e_1_3_3_269_1","first-page":"1689","article-title":"The pharmacology of fluspirilene (R 6218), a potent, long-acting and injectable neuroleptic drug","volume":"20","author":"Janssen PA","year":"1970","unstructured":"Janssen PA, Niemegeers CJ, Schellekens KH, Lenaerts FM, Verbruggen FJ, van Nueten JM, Marsboom RH, H\u00e9rin VV, Schaper WK. 1970. The pharmacology of fluspirilene (R 6218), a potent, long-acting and injectable neuroleptic drug. Arzneimittelforschung. 20(11):1689\u20131698.","journal-title":"Arzneimittelforschung"},{"key":"e_1_3_3_270_1","unstructured":"Janssen Pharmaceuticals. 2021. INVEGA HAFYERA\u2122 (paliperidone palmitate) extended-release injectable suspension for gluteal intramuscular use."},{"key":"e_1_3_3_271_1","volume-title":"INVEGA SUSTENNA\u00ae (paliperidone palmitate) extended-release injectable suspension, for intramuscular use","author":"Janssen Pharmaceuticals","year":"2009","unstructured":"Janssen Pharmaceuticals. 2009. INVEGA SUSTENNA\u00ae (paliperidone palmitate) extended-release injectable suspension, for intramuscular use. Titusville, NJ: Janssen Pharmaceuticals, Inc."},{"key":"e_1_3_3_272_1","unstructured":"Janssen Pharmaceuticals Inc. 2007. https:\/\/www.janssenlabels.com\/package-insert\/product-monograph\/prescribing-information\/INVEGA-pi.pdf (accessed 14\/04\/2024)"},{"key":"e_1_3_3_273_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181acc372"},{"key":"e_1_3_3_274_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200629090-00001"},{"key":"e_1_3_3_275_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301646"},{"key":"e_1_3_3_276_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(96)90111-3"},{"key":"e_1_3_3_277_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199408000-00006"},{"key":"e_1_3_3_278_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000585"},{"key":"e_1_3_3_279_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00432722"},{"key":"e_1_3_3_280_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00436100"},{"key":"e_1_3_3_281_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30088-4"},{"key":"e_1_3_3_282_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1990.tb03827.x"},{"key":"e_1_3_3_283_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800330013001"},{"key":"e_1_3_3_284_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181d35d6b"},{"key":"e_1_3_3_285_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2022.07.014"},{"key":"e_1_3_3_286_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(95)02037-j"},{"key":"e_1_3_3_287_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.4.514"},{"key":"e_1_3_3_288_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.6.553"},{"key":"e_1_3_3_289_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.154.11.1525"},{"key":"e_1_3_3_290_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050277"},{"key":"e_1_3_3_291_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(96)00100-5"},{"key":"e_1_3_3_292_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.7.921"},{"key":"e_1_3_3_293_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.2.286"},{"key":"e_1_3_3_294_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41397-021-00249-1"},{"key":"e_1_3_3_295_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050579"},{"key":"e_1_3_3_296_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2022.08.021"},{"key":"e_1_3_3_297_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2008.33"},{"key":"e_1_3_3_298_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301108"},{"key":"e_1_3_3_299_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(88)90163-4"},{"key":"e_1_3_3_300_1","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2011.180"},{"key":"e_1_3_3_301_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-012-2953-0"},{"key":"e_1_3_3_302_1","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.12905"},{"key":"e_1_3_3_303_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001494"},{"key":"e_1_3_3_304_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00433814"},{"issue":"4","key":"e_1_3_3_305_1","first-page":"737","article-title":"Additional studies on side effects of melperone in long-term therapy for 1 to 15 years in psychiatric patients","volume":"31","author":"Kirkegaard A","year":"1981","unstructured":"Kirkegaard A, Kirkegaard G, Geismar L, Christensen I. 1981. Additional studies on side effects of melperone in long-term therapy for 1 to 15 years in psychiatric patients. Arzneimittelforschung. 31(4):737\u2013740.","journal-title":"Arzneimittelforschung"},{"key":"e_1_3_3_306_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02316862"},{"key":"e_1_3_3_307_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1835"},{"key":"e_1_3_3_308_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199412000-00002"},{"key":"e_1_3_3_309_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-020-00894-y"},{"key":"e_1_3_3_310_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-021-01041-x"},{"key":"e_1_3_3_311_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145710001148"},{"key":"e_1_3_3_312_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-006-0098-y"},{"key":"e_1_3_3_313_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2020-0024"},{"key":"e_1_3_3_314_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2761"},{"key":"e_1_3_3_315_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881118798605"},{"key":"e_1_3_3_316_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13323"},{"key":"e_1_3_3_317_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14300"},{"key":"e_1_3_3_318_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199404000-00002"},{"key":"e_1_3_3_319_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050091"},{"key":"e_1_3_3_320_1","doi-asserted-by":"publisher","DOI":"10.1258\/0004563053857798"},{"key":"e_1_3_3_321_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40246-019-0254-y"},{"key":"e_1_3_3_322_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2017.07.011"},{"key":"e_1_3_3_323_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000065"},{"key":"e_1_3_3_324_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.152.2.179"},{"key":"e_1_3_3_325_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2005.01.001"},{"key":"e_1_3_3_326_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199937060-00001"},{"key":"e_1_3_3_327_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2008.07.010"},{"key":"e_1_3_3_328_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1094491"},{"key":"e_1_3_3_329_1","doi-asserted-by":"publisher","DOI":"10.1038\/tpj.2009.32"},{"key":"e_1_3_3_330_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3182983ffa"},{"key":"e_1_3_3_331_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1993.tb03391.x"},{"key":"e_1_3_3_332_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e328351d47f"},{"key":"e_1_3_3_333_1","first-page":"173","article-title":"Human cytochrome P4501A2","volume":"148","author":"Landi MT","year":"1999","unstructured":"Landi MT, Sinha R, Lang NP, Kadlubar FF. 1999. Human cytochrome P4501A2. IARC Sci Publ. 148:173\u2013195.","journal-title":"IARC Sci Publ"},{"key":"e_1_3_3_334_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15020673"},{"key":"e_1_3_3_335_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-3-437-21064-8.00019-2"},{"key":"e_1_3_3_336_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31825ac35c"},{"key":"e_1_3_3_337_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2571"},{"key":"e_1_3_3_338_1","doi-asserted-by":"publisher","DOI":"10.1080\/15622975.2017.1285048"},{"key":"e_1_3_3_339_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60733-3"},{"key":"e_1_3_3_340_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2019.19010034"},{"key":"e_1_3_3_341_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800330112018"},{"key":"e_1_3_3_342_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2018.04.006"},{"key":"e_1_3_3_343_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14246"},{"key":"e_1_3_3_344_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.2104"},{"key":"e_1_3_3_345_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0006-2952(98)00208-1"},{"key":"e_1_3_3_346_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291719000369"},{"key":"e_1_3_3_347_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-0763-4"},{"key":"e_1_3_3_348_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051688"},{"key":"e_1_3_3_349_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-012-0906-2"},{"key":"e_1_3_3_350_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3182356255"},{"key":"e_1_3_3_351_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199612000-00001"},{"key":"e_1_3_3_352_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(96)90165-4"},{"issue":"4","key":"e_1_3_3_353_1","first-page":"270","article-title":"Radioreceptor assay in checking serum concentration in long-term treatment with cis(z)-flupenthixol decanoate","volume":"29","author":"Lipska B","year":"1987","unstructured":"Lipska B, Welbel L, Nurowska K, Szukalski B. 1987. Radioreceptor assay in checking serum concentration in long-term treatment with cis(z)-flupenthixol decanoate. Act Nerv Super. 29(4):270\u2013273.","journal-title":"Act Nerv Super"},{"key":"e_1_3_3_354_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-015-1965-1"},{"key":"e_1_3_3_355_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2021.05.010"},{"key":"e_1_3_3_356_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199604000-00015"},{"key":"e_1_3_3_357_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2021.11.032"},{"key":"e_1_3_3_358_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.152.4.650a"},{"key":"e_1_3_3_359_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn1728"},{"key":"e_1_3_3_360_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199101000-00010"},{"key":"e_1_3_3_361_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148539"},{"key":"e_1_3_3_362_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddl166"},{"key":"e_1_3_3_363_1","unstructured":"Lundbeck H. 2023. Product monograph \u2013 Clopixol [30.01.23]. Retrieved from https:\/\/www.lundbeck.com\/content\/dam\/lundbeck-com\/americas\/canada\/products\/files\/clopixol_product_monograph_english.pdf"},{"key":"e_1_3_3_364_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.768"},{"key":"e_1_3_3_365_1","doi-asserted-by":"publisher","DOI":"10.4306\/pi.2017.14.3.360"},{"key":"e_1_3_3_366_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301409"},{"key":"e_1_3_3_367_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.5.818"},{"key":"e_1_3_3_368_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2007.06091479"},{"key":"e_1_3_3_369_1","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v69n0111"},{"key":"e_1_3_3_370_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(78)71006-6"},{"key":"e_1_3_3_371_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389200216666150602145005"},{"key":"e_1_3_3_372_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000251"},{"key":"e_1_3_3_373_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31824997a8"},{"key":"e_1_3_3_374_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0920-9964(00)00184-5"},{"key":"e_1_3_3_375_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.158.5.658"},{"issue":"3","key":"e_1_3_3_376_1","first-page":"479","article-title":"Plasma levels of parent drug and metabolites in patients receiving oral and depot fluphenazine","volume":"25","author":"Marder SR","year":"1989","unstructured":"Marder SR, Van Putten T, Aravagiri M, Hubbard JW, Hawes EM, McKay G, Midha KK. 1989. Plasma levels of parent drug and metabolites in patients receiving oral and depot fluphenazine. Psychopharmacol Bull. 25(3):479\u2013482.","journal-title":"Psychopharmacol Bull"},{"key":"e_1_3_3_377_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.154.6.881a"},{"key":"e_1_3_3_378_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245616"},{"key":"e_1_3_3_379_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007479.pub2"},{"key":"e_1_3_3_380_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199614050-00003"},{"key":"e_1_3_3_381_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-973835"},{"key":"e_1_3_3_382_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-018-0664-3"},{"key":"e_1_3_3_383_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1601396"},{"key":"e_1_3_3_384_1","first-page":"1163","article-title":"Clinical pharmacology of atypical antipsychotics: an update","volume":"13","author":"Mauri MC","year":"2014","unstructured":"Mauri MC, Paletta S, Maffini M, Colasanti A, Dragogna F, Di Pace C, Altamura AC. 2014. Clinical pharmacology of atypical antipsychotics: an update. Excli J. 13:1163\u20131191.","journal-title":"Excli J"},{"key":"e_1_3_3_385_1","doi-asserted-by":"publisher","DOI":"10.1055\/a-1113-7862"},{"key":"e_1_3_3_386_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2004.09.009"},{"key":"e_1_3_3_387_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200746050-00001"},{"key":"e_1_3_3_388_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.8.14.2207"},{"issue":"9","key":"e_1_3_3_389_1","first-page":"370","article-title":"Fluphenazine plasma levels and clinical response","volume":"45","author":"Mavroidis ML","year":"1984","unstructured":"Mavroidis ML, Kanter DR, Hirschowitz J, Garver DL. 1984. Fluphenazine plasma levels and clinical response. J Clin Psychiatry. 45(9):370\u2013373.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_3_390_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1981.01780270088012"},{"issue":"8","key":"e_1_3_3_391_1","first-page":"330","article-title":"The relationship between blood perphenazine levels, early resolution of psychotic symptoms, and side effects","volume":"51","author":"Mazure CM","year":"1990","unstructured":"Mazure CM, Nelson JC, Jatlow PI, Kincare P, Bowers MB. 1990. The relationship between blood perphenazine levels, early resolution of psychotic symptoms, and side effects. J Clin Psychiatry. 51(8):330\u2013334.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_3_392_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2022.2057297"},{"key":"e_1_3_3_393_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1076727"},{"key":"e_1_3_3_394_1","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v68n0506"},{"key":"e_1_3_3_395_1","first-page":"47","article-title":"An overview of the mechanism of action of clozapine","volume":"55","author":"Meltzer HY.","unstructured":"Meltzer HY. An overview of the mechanism of action of clozapine. J Clin Psychiatry. 55(Suppl B):47\u201352.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_3_396_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1989.tb06432.x"},{"issue":"3","key":"e_1_3_3_397_1","first-page":"390","article-title":"The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs","volume":"25","author":"Meltzer HY","year":"1989","unstructured":"Meltzer HY, Matsubara S, Lee JC. 1989. The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs. Psychopharmacol Bull. 25(3):390\u2013392.","journal-title":"Psychopharmacol Bull"},{"key":"e_1_3_3_398_1","unstructured":"Merck & Co. 2009. HIGHLIGHTS OF PRESCRIBING INFORMATION Saphris (asenapine). Retrieved from http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/022117s012lbl.pdf."},{"key":"e_1_3_3_399_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2000.00157.x"},{"key":"e_1_3_3_400_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2000.00156.x"},{"issue":"3","key":"e_1_3_3_401_1","first-page":"58","article-title":"The effect of food on the absorption of oral ziprasidone","volume":"40","author":"Miceli JJ","year":"2007","unstructured":"Miceli JJ, Glue P, Alderman J, Wilner K. 2007. The effect of food on the absorption of oral ziprasidone. Psychopharmacol Bull. 40(3):58\u201368.","journal-title":"Psychopharmacol Bull"},{"key":"e_1_3_3_402_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2000.00147.x"},{"key":"e_1_3_3_403_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1998.tb03830.x"},{"key":"e_1_3_3_404_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00181943"},{"key":"e_1_3_3_405_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1983.tb01515.x"},{"key":"e_1_3_3_406_1","doi-asserted-by":"publisher","DOI":"10.3109\/03602537908993895"},{"key":"e_1_3_3_407_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1303"},{"key":"e_1_3_3_408_1","first-page":"117","article-title":"Plasma clozapine concentrations as a predictor of clinical response: a follow-up study","volume":"55","author":"Miller DD","year":"1994","unstructured":"Miller DD, Fleming F, Holman TL, Perry PJ. 1994. Plasma clozapine concentrations as a predictor of clinical response: a follow-up study. J Clin Psychiatry. 55(Suppl B):117\u2013121.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_3_409_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2020.3643"},{"key":"e_1_3_3_410_1","first-page":"789","article-title":"Effects of SM-9018 on hepatic drug metabolizing enzyme systems in rats","volume":"31","author":"Mizuno Y","year":"1997","unstructured":"Mizuno Y, Kanemaru H, Nakatsuka I, Oosone Y, Matsuo h, Nagatsuka S, et al. 1997. Effects of SM-9018 on hepatic drug metabolizing enzyme systems in rats. Kiso to Rinsho. 31:789\u2013797.","journal-title":"Kiso to Rinsho"},{"key":"e_1_3_3_411_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.104.002576"},{"key":"e_1_3_3_412_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232438"},{"key":"e_1_3_3_413_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2010.208"},{"key":"e_1_3_3_414_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2000.00153.x"},{"key":"e_1_3_3_415_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2005.10.003"},{"key":"e_1_3_3_416_1","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2003.5.1\/fmuellerspahn"},{"key":"e_1_3_3_417_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200620030-00005"},{"key":"e_1_3_3_418_1","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12947"},{"key":"e_1_3_3_419_1","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyab071"},{"key":"e_1_3_3_420_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e3181b6326a"},{"key":"e_1_3_3_421_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S95100"},{"key":"e_1_3_3_422_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00427494"},{"key":"e_1_3_3_423_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-010-0812-7"},{"key":"e_1_3_3_424_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31824a31e6"},{"key":"e_1_3_3_425_1","unstructured":"New Drug Application 22\u2013117 (asenapine). 2008. Retrieved from https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2009\/022117s000_ClinPharmR_P2.pdf"},{"key":"e_1_3_3_426_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881110389208"},{"key":"e_1_3_3_427_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-014-3515-4"},{"key":"e_1_3_3_428_1","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyaa071"},{"key":"e_1_3_3_429_1","doi-asserted-by":"publisher","DOI":"10.2217\/17410541.5.4.367"},{"key":"e_1_3_3_430_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145711000514"},{"key":"e_1_3_3_431_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02244811"},{"key":"e_1_3_3_432_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.152.10.1444"},{"key":"e_1_3_3_433_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31816336fd"},{"key":"e_1_3_3_434_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02246302"},{"key":"e_1_3_3_435_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.6.869"},{"key":"e_1_3_3_436_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145798001229"},{"key":"e_1_3_3_437_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199511000-00003"},{"key":"e_1_3_3_438_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.152.2.173"},{"key":"e_1_3_3_439_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145713000680"},{"key":"e_1_3_3_440_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-002-1083-5"},{"issue":"1","key":"e_1_3_3_441_1","first-page":"158","article-title":"Pharmacological profile of AD-5423, a novel antipsychotic with both potent dopamine-D2 and serotonin-S2 antagonist properties","volume":"264","author":"Oka M","year":"1993","unstructured":"Oka M, Noda Y, Ochi Y, Furukawa K, Une T, Kurumiya S, Hino K, Karasawa T. 1993. Pharmacological profile of AD-5423, a novel antipsychotic with both potent dopamine-D2 and serotonin-S2 antagonist properties. J Pharmacol Exp Ther. 264(1):158\u2013165.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_3_442_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02246112"},{"issue":"4","key":"e_1_3_3_443_1","first-page":"285","article-title":"Clinical study of an injectable long-acting neuroleptic agent: fluspirilene (R 6218)","volume":"73","author":"Onkenhout LA","year":"1970","unstructured":"Onkenhout LA, Scheffer W, Amery W. 1970. Clinical study of an injectable long-acting neuroleptic agent: fluspirilene (R 6218). Psychiatr Neurol Neurochir. 73(4):285\u2013291.","journal-title":"Psychiatr Neurol Neurochir"},{"key":"e_1_3_3_444_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41397-020-0173-2"},{"key":"e_1_3_3_445_1","unstructured":"Otsuka Pharmaceutical Co. 2021. HIGHLIGHTS OF PRESCRIBING INFORMATION REXULTI\u00ae (brexpiprazole) tablets for oral use. Retrieved from Rockville MD: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/205422s007lbl.pdf"},{"key":"e_1_3_3_446_1","unstructured":"Otsuka Pharmaceutical Co. 2016. Aripiprazole: highlights of prescribing information. doi: https:\/\/www.otsukaus.com\/sites\/g\/fles\/qhldwo5616\/fles\/media\/static\/Abilify-PI.pdf"},{"key":"e_1_3_3_447_1","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2010.46.3.1476499"},{"key":"e_1_3_3_448_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e32801a3c10"},{"key":"e_1_3_3_449_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200112000-00011"},{"key":"e_1_3_3_450_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(97)90037-0"},{"key":"e_1_3_3_451_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-021-01298-w"},{"issue":"10","key":"e_1_3_3_452_1","first-page":"379","article-title":"Relation of serum molindone levels to serum prolactin levels and antipsychotic response","volume":"50","author":"Pandurangi AK","year":"1989","unstructured":"Pandurangi AK, Narasimhachari N, Blackard WG, Landa BS. 1989. Relation of serum molindone levels to serum prolactin levels and antipsychotic response. J Clin Psychiatry. 50(10):379\u2013381.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_3_453_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(23)00002-0"},{"key":"e_1_3_3_454_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2019.18050589"},{"key":"e_1_3_3_455_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2021.3799"},{"key":"e_1_3_3_456_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e3182708ec5"},{"key":"e_1_3_3_457_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13255"},{"key":"e_1_3_3_458_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2017.03.002"},{"key":"e_1_3_3_459_1","unstructured":"Roth Lab. 2024. PDSP Ki database. Retrieved from Accessed from https:\/\/pdsp.unc.edu\/databases\/pdsp.php (Accessed 2024 May 8)."},{"key":"e_1_3_3_460_1","doi-asserted-by":"publisher","DOI":"10.2165\/11590490-000000000-00000"},{"key":"e_1_3_3_461_1","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2016.96"},{"key":"e_1_3_3_462_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2011.12.019"},{"key":"e_1_3_3_463_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200418002-00003"},{"key":"e_1_3_3_464_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200102000-00004"},{"key":"e_1_3_3_465_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.148.2.231"},{"key":"e_1_3_3_466_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199712000-00006"},{"issue":"1","key":"e_1_3_3_467_1","first-page":"25","article-title":"Parametric PET imaging of 5HT2A receptor distribution with 18F-setoperone in the normal human neocortex","volume":"40","author":"Petit-Tabou\u00e9 MC","year":"1999","unstructured":"Petit-Tabou\u00e9 MC, Landeau B, Barr\u00e9 L, Onfroy MC, No\u00ebl MH, Baron JC. 1999. Parametric PET imaging of 5HT2A receptor distribution with 18F-setoperone in the normal human neocortex. J Nucl Med. 40(1):25\u201332.","journal-title":"J Nucl Med"},{"key":"e_1_3_3_468_1","unstructured":"PharmGKB. Clinical Annotation for CYP3A4*1 CYP3A4*20 CYP3A4*22; quetiapine (level 1A Metabolism\/PK). Retrieved from 2024 https:\/\/www.pharmgkb.org\/clinicalAnnotation\/1451147720"},{"key":"e_1_3_3_469_1","unstructured":"PharmGKB. PharmGKB clinical annotations on lurasidone. Retrieved from 2023 https:\/\/www.pharmgkb.org\/chemical\/PA166129557\/clinicalAnnotation"},{"issue":"8","key":"e_1_3_3_470_1","first-page":"1302","article-title":"Relationship between perazine serum concentration and clinical results in long-term treated schizophrenic outpatients","volume":"28","author":"Pietzcker A","year":"1978","unstructured":"Pietzcker A, Poppenberg A, Schley J, M\u00fcller-Oerlinghausen B. 1978. Relationship between perazine serum concentration and clinical results in long-term treated schizophrenic outpatients. Arzneimittelforschung. 28(8):1302\u20131303.","journal-title":"Arzneimittelforschung"},{"key":"e_1_3_3_471_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01833160"},{"key":"e_1_3_3_472_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3182a4ee2c"},{"key":"e_1_3_3_473_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)63079-6"},{"key":"e_1_3_3_474_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050223"},{"key":"e_1_3_3_475_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12991-015-0053-3"},{"key":"e_1_3_3_476_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1299910"},{"key":"e_1_3_3_477_1","first-page":"133","article-title":"Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia","volume":"55","author":"Potkin SG","year":"1994","unstructured":"Potkin SG, Bera R, Gulasekaram B, Costa J, Hayes S, Jin Y, Richmond G, Carreon D, Sitanggan K, Gerber B, et\u00a0al. 1994. Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia. J Clin Psychiatry. 55(Suppl B):133\u2013136.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_3_478_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n1004"},{"key":"e_1_3_3_479_1","doi-asserted-by":"publisher","DOI":"10.1017\/S109285291300059X"},{"key":"e_1_3_3_480_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2000.00151.x"},{"issue":"7","key":"e_1_3_3_481_1","first-page":"863","article-title":"Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans","volume":"25","author":"Prakash C","year":"1997","unstructured":"Prakash C, Kamel A, Gummerus J, Wilner K. 1997. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans. Drug Metab Dispos. 25(7):863\u2013872.","journal-title":"Drug Metab Dispos"},{"key":"e_1_3_3_482_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2338"},{"key":"e_1_3_3_483_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200544110-00002"},{"key":"e_1_3_3_484_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.pra.0000445247.54048.68"},{"key":"e_1_3_3_485_1","doi-asserted-by":"publisher","DOI":"10.1002\/jssc.201701315"},{"key":"e_1_3_3_486_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01932456"},{"key":"e_1_3_3_487_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002280000192"},{"key":"e_1_3_3_488_1","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200102060-00001"},{"key":"e_1_3_3_489_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pscychresns.2019.111007"},{"key":"e_1_3_3_490_1","doi-asserted-by":"publisher","DOI":"10.1038\/tpj.2017.38"},{"key":"e_1_3_3_491_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e32835ac9da"},{"key":"e_1_3_3_492_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127602"},{"key":"e_1_3_3_493_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2014.09.038"},{"key":"e_1_3_3_494_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.14.54"},{"key":"e_1_3_3_495_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.137.6.518"},{"key":"e_1_3_3_496_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-010-1941-5"},{"key":"e_1_3_3_497_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145714000777"},{"key":"e_1_3_3_498_1","volume-title":"Akute vergiftungen und arzneimittel\u00fcberdosierungen","author":"Regenthal R","unstructured":"Regenthal R, Ludewig R. (Eds.). Akute vergiftungen und arzneimittel\u00fcberdosierungen. WVG Stuttgart; 2015. ISBN: 978-3-8047-3211-7."},{"key":"e_1_3_3_499_1","doi-asserted-by":"publisher","DOI":"10.1023\/a:1009935116877"},{"key":"e_1_3_3_500_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13318-014-0247-0"},{"key":"e_1_3_3_501_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0611-0"},{"issue":"10","key":"e_1_3_3_502_1","first-page":"15","article-title":"D2 and 5-HT2 receptor effects of antipsychotics: bridging basic and clinical findings using PET","volume":"60","author":"Remington G","year":"1999","unstructured":"Remington G, Kapur, S. 1999. D2 and 5-HT2 receptor effects of antipsychotics: bridging basic and clinical findings using PET. J Clin Psychiatry. 60(Suppl 10):15\u201319.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_3_503_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.163.3.396"},{"key":"e_1_3_3_504_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.133.6.646"},{"key":"e_1_3_3_505_1","doi-asserted-by":"publisher","DOI":"10.1520\/JFS14697J"},{"key":"e_1_3_3_506_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.11m07572"},{"key":"e_1_3_3_507_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.320"},{"key":"e_1_3_3_508_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1999.00898.x"},{"key":"e_1_3_3_509_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2005.11.032"},{"key":"e_1_3_3_510_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2014.50"},{"key":"e_1_3_3_511_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00432123"},{"key":"e_1_3_3_512_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119827959"},{"key":"e_1_3_3_513_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-020-05698-3"},{"key":"e_1_3_3_514_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1819.2007.01633.x"},{"key":"e_1_3_3_515_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000215347.93902.3e"},{"key":"e_1_3_3_516_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-007-0313-5"},{"key":"e_1_3_3_517_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-017-2323-2"},{"key":"e_1_3_3_518_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.48.2.170"},{"key":"e_1_3_3_519_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-018-0230-7"},{"key":"e_1_3_3_520_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2017.05.156"},{"key":"e_1_3_3_521_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2009.04.006"},{"key":"e_1_3_3_522_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40211-014-0097-7"},{"key":"e_1_3_3_523_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000001092"},{"key":"e_1_3_3_524_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0925-4927(97)00044-9"},{"key":"e_1_3_3_525_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-2999(01)01188-8"},{"key":"e_1_3_3_526_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2017.11.009"},{"key":"e_1_3_3_527_1","article-title":"Therapeutic drug monitoring of long-acting injectable antipsychotic drugs","author":"Schoretsanitis G","year":"2020","unstructured":"Schoretsanitis G, Baumann P, Conca A, Dietmaier O, Giupponi G, Grunder G, Hahn M, Hart X, Havemann-Reinecke U, Hefner G, Kuzin M, Mossner R, Piacentino D, Steimer W, Zernig G, Hiemke C. 2020. Therapeutic drug monitoring of long-acting injectable antipsychotic drugs. Ther Drug Monit.","journal-title":"Ther Drug Monit"},{"key":"e_1_3_3_528_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-021-01257-9"},{"key":"e_1_3_3_529_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.19cs13169"},{"key":"e_1_3_3_530_1","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2019.1617695"},{"key":"e_1_3_3_531_1","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2017.1345623"},{"key":"e_1_3_3_532_1","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2018.1478727"},{"key":"e_1_3_3_533_1","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.69.399"},{"key":"e_1_3_3_534_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245606"},{"key":"e_1_3_3_535_1","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyv036"},{"key":"e_1_3_3_536_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0006-3223(97)00442-3"},{"key":"e_1_3_3_537_1","unstructured":"2019. Secuado full prescribing information [accessed 2022 Nov 11]. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/212268s000lbl.pdf."},{"key":"e_1_3_3_538_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.6.876"},{"key":"e_1_3_3_539_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1211299"},{"key":"e_1_3_3_540_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02247478"},{"key":"e_1_3_3_541_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000236659.93415.4a"},{"key":"e_1_3_3_542_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-011-2343-z"},{"key":"e_1_3_3_543_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.114.058818"},{"key":"e_1_3_3_544_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.05.007"},{"issue":"2","key":"e_1_3_3_545_1","first-page":"263","article-title":"A major plasma metabolite of chlorpromazine in a population of chronic schizophrenics","volume":"14","author":"Sgaragli G","year":"1986","unstructured":"Sgaragli G, Ninci R, Della Corte L, Valoti M, Nardini M, Andreoli V, Moneti G. 1986. A major plasma metabolite of chlorpromazine in a population of chronic schizophrenics. Drug Metab Dispos. 14(2):263\u2013266.","journal-title":"Drug Metab Dispos"},{"key":"e_1_3_3_546_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2002.01627.x"},{"key":"e_1_3_3_547_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881107082944"},{"key":"e_1_3_3_548_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009777.pub2"},{"key":"e_1_3_3_549_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-018-0134-6"},{"key":"e_1_3_3_550_1","doi-asserted-by":"publisher","DOI":"10.1080\/004982599238623"},{"key":"e_1_3_3_551_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300123"},{"key":"e_1_3_3_552_1","doi-asserted-by":"publisher","DOI":"10.15420\/aer.2018.29.2"},{"key":"e_1_3_3_553_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000532"},{"key":"e_1_3_3_554_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.135.1.99"},{"issue":"5","key":"e_1_3_3_555_1","first-page":"22","article-title":"Blood levels of neuroleptics: state of the art","volume":"46","author":"Simpson GM","year":"1985","unstructured":"Simpson GM, Yadalam, K. 1985. Blood levels of neuroleptics: state of the art. J Clin Psychiatry. 46(5\u2009Pt 2):22\u201328.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"e_1_3_3_556_1","first-page":"29","article-title":"A neurochemical basis for the antipsychotic activity of loxapine: interactions with dopamine D1, D2, D4 and serotonin 5-HT2 receptor subtypes","volume":"21","author":"Singh AN","year":"1996","unstructured":"Singh AN, Barlas C, Singh S, Franks P, Mishra RK. 1996. A neurochemical basis for the antipsychotic activity of loxapine: interactions with dopamine D1, D2, D4 and serotonin 5-HT2 receptor subtypes. J Psychiatry Neurosci. 21(1):29\u201335.","journal-title":"J Psychiatry Neurosci"},{"key":"e_1_3_3_557_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100188"},{"key":"e_1_3_3_558_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200208000-00010"},{"key":"e_1_3_3_559_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e318204d9e2"},{"key":"e_1_3_3_560_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(88)90048-0"},{"key":"e_1_3_3_561_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-00888-1"},{"key":"e_1_3_3_562_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.13.120"},{"key":"e_1_3_3_563_1","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S117321"},{"key":"e_1_3_3_564_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200004000-00009"},{"key":"e_1_3_3_565_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007997709115285"},{"key":"e_1_3_3_566_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.711940"},{"key":"e_1_3_3_567_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2009.01429.x"},{"key":"e_1_3_3_568_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09r05060gre"},{"key":"e_1_3_3_569_1","doi-asserted-by":"publisher","DOI":"10.1097\/chi.0b013e31812eed10"},{"key":"e_1_3_3_570_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0621-y"},{"key":"e_1_3_3_571_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00491981"},{"key":"e_1_3_3_572_1","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-022-00440-6"},{"key":"e_1_3_3_573_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1267178"},{"key":"e_1_3_3_574_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-005-2161-2"},{"key":"e_1_3_3_575_1","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20567"},{"key":"e_1_3_3_576_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2013.02.018"},{"key":"e_1_3_3_577_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-815513"},{"key":"e_1_3_3_578_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-017-4728-0"},{"key":"e_1_3_3_579_1","unstructured":"Sumitomo Pharma. 2022. Package insert of Lullan Tablets."},{"key":"e_1_3_3_580_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1835612100"},{"key":"e_1_3_3_581_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(91)80397-u"},{"key":"e_1_3_3_582_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200108000-00009"},{"key":"e_1_3_3_583_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004060170053"},{"key":"e_1_3_3_584_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050519"},{"key":"e_1_3_3_585_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2017.01.005"},{"key":"e_1_3_3_586_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2393"},{"key":"e_1_3_3_587_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1819.2011.02311.x"},{"key":"e_1_3_3_588_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001383"},{"key":"e_1_3_3_589_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-013-3012-1"},{"key":"e_1_3_3_590_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000070"},{"key":"e_1_3_3_591_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2010.03.027"},{"issue":"1","key":"e_1_3_3_592_1","first-page":"95","article-title":"Nonadherence to antipsychotic treatment in patients with schizophrenic disorders","volume":"28","author":"Svestka J","year":"2007","unstructured":"Svestka J, Bitter I. 2007. Nonadherence to antipsychotic treatment in patients with schizophrenic disorders. Neuro Endocrinol Lett. 28(Suppl 1):95\u2013116.","journal-title":"Neuro Endocrinol Lett"},{"issue":"3","key":"e_1_3_3_593_1","first-page":"145","article-title":"[Results of treatment of schizophrenic and schizoaffective patients with sulpiride (eglonyl alkaloid) in comparison with perphenazine (Perfenazin spofa)]","volume":"86","author":"Svestka J","year":"1990","unstructured":"Svestka J, Rys\u00e1nek R, N\u00e1hunek K, Ceskov\u00e1 E. 1990. [Results of treatment of schizophrenic and schizoaffective patients with sulpiride (eglonyl alkaloid) in comparison with perphenazine (Perfenazin spofa)]. Cesk Psychiatr. 86(3):145\u2013156.","journal-title":"Cesk Psychiatr"},{"key":"e_1_3_3_594_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200464150-00010"},{"key":"e_1_3_3_595_1","doi-asserted-by":"publisher","DOI":"10.2217\/epi-2017-0086"},{"key":"e_1_3_3_596_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200004000-00010"},{"key":"e_1_3_3_597_1","doi-asserted-by":"publisher","DOI":"10.1177\/20451253211034019"},{"issue":"1","key":"e_1_3_3_598_1","first-page":"89","article-title":"Inhibitory effects of neuroleptics on debrisoquine oxidation in man","volume":"22","author":"Syv\u00e4lahti EK","year":"1986","unstructured":"Syv\u00e4lahti EK, Lindberg R, Kallio J, De Vocht M. 1986. Inhibitory effects of neuroleptics on debrisoquine oxidation in man. Br J Clin Pharmacol. 22(1):89\u201392.","journal-title":"Br J Clin Pharmacol"},{"key":"e_1_3_3_599_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-979221"},{"key":"e_1_3_3_600_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000048"},{"key":"e_1_3_3_601_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-011-2633-5"},{"key":"e_1_3_3_602_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2005.06.011"},{"key":"e_1_3_3_603_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145705006103"},{"key":"e_1_3_3_604_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2017.05.006"},{"key":"e_1_3_3_605_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2011.07.001"},{"key":"e_1_3_3_606_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-004-1802-1"},{"key":"e_1_3_3_607_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-020-05746-y"},{"key":"e_1_3_3_608_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199802000-00021"},{"key":"e_1_3_3_609_1","doi-asserted-by":"publisher","DOI":"10.1177\/0004563217731432"},{"key":"e_1_3_3_610_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3182825bce"},{"key":"e_1_3_3_611_1","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyy004"},{"key":"e_1_3_3_612_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001009"},{"key":"e_1_3_3_613_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-002-1082-6"},{"key":"e_1_3_3_614_1","volume-title":"The maudsley prescribing guidelines in psychiatry","author":"Taylor DM","year":"2018","unstructured":"Taylor DM, Barnes TRE, Young AH. 2018. The maudsley prescribing guidelines in psychiatry. 13th Edition. Oxford, United Kingdom: John Wiley & Sons.","edition":"13"},{"key":"e_1_3_3_615_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1987.tb03021.x"},{"key":"e_1_3_3_616_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.150.3.334"},{"key":"e_1_3_3_617_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jctc.0c00013"},{"key":"e_1_3_3_618_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1977.tb00148.x"},{"key":"e_1_3_3_619_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-979584"},{"key":"e_1_3_3_620_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2020.20071039"},{"key":"e_1_3_3_621_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2004.03.016"},{"key":"e_1_3_3_622_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13070935"},{"issue":"6","key":"e_1_3_3_623_1","first-page":"417","article-title":"Plasma concentrations of antipsychotic drugs in psychiatric inpatients","volume":"51","author":"Tokunaga H","year":"1997","unstructured":"Tokunaga H, Kudo K, Imamura T, Jitsufuchi N, Ohtsuka Y, Ikeda N. 1997. Plasma concentrations of antipsychotic drugs in psychiatric inpatients. Nihon Hoigaku Zasshi. 51(6):417\u2013422.","journal-title":"Nihon Hoigaku Zasshi"},{"key":"e_1_3_3_624_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001545"},{"key":"e_1_3_3_625_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dmpk.2020.03.006"},{"key":"e_1_3_3_626_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.115.067900"},{"key":"e_1_3_3_627_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-023-01247-1"},{"key":"e_1_3_3_628_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.4.505"},{"key":"e_1_3_3_629_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-004216"},{"key":"e_1_3_3_630_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2019.05.014"},{"key":"e_1_3_3_631_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.146.4.439"},{"key":"e_1_3_3_632_1","doi-asserted-by":"publisher","DOI":"10.1080\/00048678709160929"},{"key":"e_1_3_3_633_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-019-02768-0"},{"key":"e_1_3_3_634_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000961"},{"key":"e_1_3_3_635_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-020-03002-y"},{"key":"e_1_3_3_636_1","unstructured":"U.S. Food and Drug Administration. 2022. Table of Pharmacogenetic Associations. https:\/\/www.fda.gov\/medical-devices\/precision-medicine\/table-pharmacogenetic-associations#about."},{"key":"e_1_3_3_637_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.105.007369"},{"key":"e_1_3_3_638_1","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v69n0811"},{"key":"e_1_3_3_639_1","doi-asserted-by":"publisher","DOI":"10.1097\/JGP.0b013e318265738f"},{"key":"e_1_3_3_640_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000065"},{"key":"e_1_3_3_641_1","doi-asserted-by":"publisher","DOI":"10.5414\/cpp41003"},{"key":"e_1_3_3_642_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199834030-00005"},{"issue":"6","key":"e_1_3_3_643_1","first-page":"445","article-title":"Dehalogenation and N-dealkylation of chlorpromazine as revealed by plasma concentrations of metabolites in a population of chronically medicated schizophrenics","volume":"14","author":"Valoti M","year":"1992","unstructured":"Valoti M, Palmi M, Della Corte L, Nardini M, Corti P, Sgaragli GP. 1992. Dehalogenation and N-dealkylation of chlorpromazine as revealed by plasma concentrations of metabolites in a population of chronically medicated schizophrenics. Methods Find Exp Clin Pharmacol. 14(6):445\u2013450.","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"e_1_3_3_644_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.110.036715"},{"key":"e_1_3_3_645_1","doi-asserted-by":"publisher","DOI":"10.1097\/YPG.0000000000000320"},{"key":"e_1_3_3_646_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200303000-00006"},{"key":"e_1_3_3_647_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000319"},{"issue":"4","key":"e_1_3_3_648_1","first-page":"277","article-title":"Experience with fluspirilene (R 6218), a long-acting neuroleptic","volume":"73","author":"van Epen JH.","year":"1970","unstructured":"van Epen JH. 1970. Experience with fluspirilene (R 6218), a long-acting neuroleptic. Psychiatr Neurol Neurochir. 73(4):277\u2013284.","journal-title":"Psychiatr Neurol Neurochir"},{"key":"e_1_3_3_649_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/17.2.197"},{"key":"e_1_3_3_650_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.153.12.1579"},{"key":"e_1_3_3_651_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S124658"},{"key":"e_1_3_3_652_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2018.07.002"},{"key":"e_1_3_3_653_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.107.018275"},{"key":"e_1_3_3_654_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31818ba2f6"},{"key":"e_1_3_3_655_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145710000374"},{"key":"e_1_3_3_656_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145704004353"},{"key":"e_1_3_3_657_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001131"},{"key":"e_1_3_3_658_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-009-0640-9"},{"key":"e_1_3_3_659_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881120985102"},{"key":"e_1_3_3_660_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2008.09.003"},{"key":"e_1_3_3_661_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2008.09.012"},{"key":"e_1_3_3_662_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14626"},{"key":"e_1_3_3_663_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270004266621"},{"key":"e_1_3_3_664_1","doi-asserted-by":"publisher","DOI":"10.1002\/syn.10053"},{"key":"e_1_3_3_665_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.1130010203"},{"key":"e_1_3_3_666_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.27.77"},{"key":"e_1_3_3_667_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.25.885"},{"key":"e_1_3_3_668_1","doi-asserted-by":"publisher","DOI":"10.2165\/11200860-000000000-00000"},{"key":"e_1_3_3_669_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(92)80554-4"},{"key":"e_1_3_3_670_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2290"},{"key":"e_1_3_3_671_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2020.03.006"},{"key":"e_1_3_3_672_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.22r14626"},{"key":"e_1_3_3_673_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.770"},{"key":"e_1_3_3_674_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2350"},{"key":"e_1_3_3_675_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00558453"},{"key":"e_1_3_3_676_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1989.tb06433.x"},{"key":"e_1_3_3_677_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00439443"},{"key":"e_1_3_3_678_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2000.00148.x"},{"key":"e_1_3_3_679_1","doi-asserted-by":"publisher","DOI":"10.1177\/026988110101500212"},{"key":"e_1_3_3_680_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbx007"},{"key":"e_1_3_3_681_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00433729"},{"key":"e_1_3_3_682_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1978.tb06929.x"},{"key":"e_1_3_3_683_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2014.05.005"},{"key":"e_1_3_3_684_1","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-020-00089-z"},{"key":"e_1_3_3_685_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705195"},{"key":"e_1_3_3_686_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.146.7.905"},{"key":"e_1_3_3_687_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-013-3103-z"},{"key":"e_1_3_3_688_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-020-03021-9"},{"key":"e_1_3_3_689_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2008.166"},{"key":"e_1_3_3_690_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2005.10.008"},{"key":"e_1_3_3_691_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(97)90063-1"},{"key":"e_1_3_3_692_1","doi-asserted-by":"publisher","DOI":"10.1021\/js970446m"},{"key":"e_1_3_3_693_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-081X(199708)18:6<533::AID-BDD42>3.0.CO;2-J"},{"issue":"5","key":"e_1_3_3_694_1","first-page":"158","article-title":"Suicide with prothipendyl","volume":"193","author":"Wu M","year":"1994","unstructured":"Wu M, Schmitt G, Mattern R. 1994. Suicide with prothipendyl. Arch Kriminol. 193(5\u20136):158\u2013162.","journal-title":"Arch Kriminol"},{"key":"e_1_3_3_695_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbu220"},{"key":"e_1_3_3_696_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2006.01.011"},{"key":"e_1_3_3_697_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200104000-00013"},{"key":"e_1_3_3_698_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2020.113470"},{"key":"e_1_3_3_699_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1998.tb01416.x"},{"key":"e_1_3_3_700_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0278-5846(98)00019-0"},{"key":"e_1_3_3_701_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200408000-00004"},{"key":"e_1_3_3_702_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0278-5846(01)00218-4"},{"key":"e_1_3_3_703_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1819.2002.00936.x"},{"key":"e_1_3_3_704_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881109104849"},{"key":"e_1_3_3_705_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2005.06.019"},{"key":"e_1_3_3_706_1","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyx066"},{"key":"e_1_3_3_707_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.139.2.174"},{"key":"e_1_3_3_708_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00432687"},{"key":"e_1_3_3_709_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(02)00304-4"},{"key":"e_1_3_3_710_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41397-019-0101-5"},{"key":"e_1_3_3_711_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(18)30049-X"},{"key":"e_1_3_3_712_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e32819f8f17"},{"key":"e_1_3_3_713_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-56015-1_8-1"},{"key":"e_1_3_3_714_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2018.17121363"},{"key":"e_1_3_3_715_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2020-0134"},{"key":"e_1_3_3_716_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12780"},{"key":"e_1_3_3_717_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.11.105"},{"key":"e_1_3_3_718_1","doi-asserted-by":"publisher","DOI":"10.2165\/11318070-000000000-00000"},{"key":"e_1_3_3_719_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00177"},{"key":"e_1_3_3_720_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13101573"},{"key":"e_1_3_3_721_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.111087"},{"key":"e_1_3_3_722_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2021-0051"},{"key":"e_1_3_3_723_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200205000-00008"}],"container-title":["The World Journal of Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15622975.2024.2366235","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T14:03:33Z","timestamp":1729605813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15622975.2024.2366235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":722,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,10,20]]}},"alternative-id":["10.1080\/15622975.2024.2366235"],"URL":"https:\/\/doi.org\/10.1080\/15622975.2024.2366235","relation":{},"ISSN":["1562-2975","1814-1412"],"issn-type":[{"value":"1562-2975","type":"print"},{"value":"1814-1412","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iwbp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iwbp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-11-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}